成人血液病患者侵袭性真菌病诊疗标准:预防与治疗的权衡
本文讨论成人血液病患者侵袭性真菌感染(尤其霉菌病)的防治策略,比较普遍抗真菌预防与基于影像学及真菌学诊断方法(阴性预测值良好至优秀)的靶向策略。早期诊断和及时充分干预对改善预后至关重要,但依赖快速敏感的诊断工具。两种策略各有优劣,需等待对比临床研究结果,本文为高危患者预防及靶向诊断策略均提供依据。
要点
- 侵袭性霉菌病在成人血液病患者中粗死亡率仍高,尤其诊断延迟时。
- 早期诊断依赖快速敏感工具,是及时充分抗真菌干预、改善预后的关键。
- 普遍预防与基于影像/真菌学诊断的靶向策略孰优孰劣尚无定论,需对比研究。
核心结论
- 在对比临床研究结果出来前,普遍抗真菌预防与基于影像学和真菌学诊断的靶向策略均有其合理性。
研究设计与样本
- 本文为针对成人血液病患者侵袭性真菌病防治策略的论述/辩论性文章,非原始研究,未报告样本量。
主要发现
- 尽管有四类抗真菌药物可用,成人血液病患者侵袭性真菌感染(尤其霉菌病)粗死亡率仍高,诊断延迟时尤为明显。
- 经验性治疗策略 popularity 有所下降,而普遍预防与靶向诊断策略的优劣仍无定论。
关键数值与推荐
- 靶向策略基于放射学与真菌学诊断方法,其阴性预测值为良好至优秀,用于排除侵袭性真菌病。
临床怎么用
- 对高危血液病患者可考虑普遍抗真菌预防;也可基于真菌学、影像学、免疫学(及遗传学)方法的合理使用采取靶向策略。
- 应重视早期诊断,依赖快速敏感的诊断工具以及时启动充分抗真菌干预。
局限性
- 普遍预防与靶向策略的利弊尚无对比临床研究结果,全球支持者与反对者仍存争论。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Despite the availability of four different classes of antifungal agents, invasive fungal infections, in particular mould diseases, continue to have a high crude mortality rate in adult haematology patients, especially when diagnosed late. Early diagnosis, resulting in prompt and adequate antifungal intervention, is of great importance when trying to improve the overall outcome of these infections, but depends on the availability of rapid and sensitive diagnostic tools. The medical community has developed and continues to evaluate a continuum of antifungal strategies (starting with prophylaxis followed by empirical therapy and more recently a diagnostic-driven or pre-emptive approach) to better tackle these life-threatening diseases. While the empirical approach seems to have lost some of its popularity, the jury is still out about the pros and cons of universal antifungal prophylaxis in at-risk adult haematology patients compared with an approach that uses radiological and mycological diagnostic methods with good to excellent negative predictive values (also erroneously called pre-emptive), trying to exclude the presence of an invasive fungal disease. Whilst awaiting the results of comparative clinical studies, believers and non-believers around the globe continue to argue about the advantages and shortcomings of both strategies. The debate presented here provides a rationale for both prophylaxis for 'high-risk' haematology patients as well as for a more targeted approach based on the appropriate use of mycological, radiological, immunological (and genetic) methods for the diagnosis of invasive fungal diseases.
引用
- Barnes R, Rogers T, Maertens J, et al. Defining standards of CARE for invasive fungal diseases in adult haematology patients: antifungal prophylaxis versus treatment. J Antimicrob Chemother. 2019. PMID: 31222310. doi:10.1093/jac/dkz040
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。